Contact this trialFirst, we need to learn more about you.
Janus Kinase Inhibitor
KRT-232 or TL-895 for Myelofibrosis
Recruiting1 awardPhase 2
Glendale, California
This trial will study two different drugs to treat myelofibrosis in patients who have not received treatment before. The first stage will evaluate the safety and effectiveness of the drugs, and the second stage will enroll more patients in the successful drug group.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service